Yuyu Pharma, Inc. (KRX:000220)

South Korea · Delayed Price · Currency is KRW

3,775.00

-60.00 (-1.56%)

Last updated: Aug 12, 2026, 2:15 PM KST

-14.59% (1Y)

Market Cap	60.39B -15.8%
Revenue (ttm)	143.52B +8.2%
Net Income	8.65B +47.5%
EPS	536.27 +43.6%
Shares Out	15.75M
PE Ratio	7.15
Forward PE	n/a
Dividend	100.00 (2.66%)
Ex-Dividend Date	n/a

Volume	25,053
Open	3,810.00
Previous Close	3,835.00
Day's Range	3,770.00 - 3,830.00
52-Week Range	3,320.00 - 5,100.00
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About Yuyu Pharma

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1941

Employees 254

Stock Exchange Korea Stock Exchange

Ticker Symbol 000220

Full Company Profile

Financial Performance

In 2025, Yuyu Pharma's revenue was 140.88 billion, an increase of 5.81% compared to the previous year's 133.15 billion. Earnings were 7.83 billion, a decrease of -10.21%.

Financial Statements